Literature DB >> 6728001

Expression and amplification of the N-myc gene in primary retinoblastoma.

W H Lee, A L Murphree, W F Benedict.   

Abstract

Retinoblastoma, the most common intraocular tumour of childhood, probably arises from embryonal cells and occurs in hereditary and non-hereditary forms. Recent evidence suggests that this retinoblastoma (Rb) susceptibility gene located at chromosome 13q14 is actually recessive. Knudson has proposed that the tumour is caused by two mutational events. This idea was extended by Comings, who suggested that dominantly inherited tumours may result from loss or inactivation of both alleles of regulatory or suppressor genes that, when active, prevent the expression of a structural transforming gene(s) (possibly an oncogene) normally active only during embryogenesis. Despite circumstantial evidence for this hypothesis, no activated oncogene has been identified. We now report that (1) the N-myc gene is amplified 10-200-fold in two primary retinoblastomas and a retinoblastoma cell line Y79 and (2) expression of N-myc gene is highly elevated in most of the retinoblastomas examined. This finding suggests that N-myc gene may have a primary role in the tumorigenesis of retinoblastoma.

Entities:  

Mesh:

Year:  1984        PMID: 6728001     DOI: 10.1038/309458a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  106 in total

1.  Two N-myc polypeptides with distinct amino termini encoded by the second and third exons of the gene.

Authors:  T P Mäkelä; K Saksela; K Alitalo
Journal:  Mol Cell Biol       Date:  1989-04       Impact factor: 4.272

2.  Abnormal distribution of c-myc oncogene product in familial adenomatous polyposis.

Authors:  V Sundaresan; I C Forgacs; D G Wight; B Wilson; G I Evan; J V Watson
Journal:  J Clin Pathol       Date:  1987-11       Impact factor: 3.411

3.  Subtype-specific FBXW7 mutation and MYCN copy number gain in Wilms' tumor.

Authors:  Richard D Williams; Reem Al-Saadi; Tasnim Chagtai; Sergey Popov; Boo Messahel; Neil Sebire; Manfred Gessler; Jenny Wegert; Norbert Graf; Ivo Leuschner; Mike Hubank; Chris Jones; Gordan Vujanic; Kathy Pritchard-Jones
Journal:  Clin Cancer Res       Date:  2010-03-23       Impact factor: 12.531

4.  The microRNA miR-7 regulates Tramtrack69 in a developmental switch in Drosophila follicle cells.

Authors:  Yi-Chun Huang; Laila Smith; John Poulton; Wu-Min Deng
Journal:  Development       Date:  2013-01-16       Impact factor: 6.868

5.  Nucleotide sequence of the human N-myc gene.

Authors:  L W Stanton; M Schwab; J M Bishop
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

6.  Human small-cell lung cancers show amplification and expression of the N-myc gene.

Authors:  M M Nau; B J Brooks; D N Carney; A F Gazdar; J F Battey; E A Sausville; J D Minna
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

7.  Detection of N-myc gene amplification by fluorescence in situ hybridization. Diagnostic utility for neuroblastoma.

Authors:  D N Shapiro; M B Valentine; S T Rowe; A E Sinclair; J E Sublett; W M Roberts; A T Look
Journal:  Am J Pathol       Date:  1993-05       Impact factor: 4.307

8.  Human proto-oncogene N-myc encodes nuclear proteins that bind DNA.

Authors:  G Ramsay; L Stanton; M Schwab; J M Bishop
Journal:  Mol Cell Biol       Date:  1986-12       Impact factor: 4.272

9.  A detailed analysis of chromosomal changes in heritable and non-heritable retinoblastoma.

Authors:  J Squire; B L Gallie; R A Phillips
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

10.  MYCN promotes the expansion of Phox2B-positive neuronal progenitors to drive neuroblastoma development.

Authors:  Goleeta Alam; Hongjuan Cui; Huilin Shi; Liqun Yang; Jane Ding; Ling Mao; William A Maltese; Han-Fei Ding
Journal:  Am J Pathol       Date:  2009-07-16       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.